<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02141633</url>
  </required_header>
  <id_info>
    <org_study_id>20120896</org_study_id>
    <nct_id>NCT02141633</nct_id>
    <nct_alias>NCT02026375</nct_alias>
  </id_info>
  <brief_title>Airway and Pulmonary Vascular Endothelial Function in Healthy Smokers: Effect of Inhaled Glucocorticosteroid Treatment</brief_title>
  <acronym>smoker3</acronym>
  <official_title>Airway and Pulmonary Vascular Endothelial Function in Healthy Smokers: Effect of Inhaled Glucocorticosteroid Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Miami</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Miami</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purposes of the present proposal are to 1) compare inhaled albuterol-induced changes in
      airway blood flow (Qaw), and in CO and Ppas in healthy current smokers and lifetime
      non-smokers as an index of endothelial function in the airway and pulmonary circulations, 2)
      compare the results between smokers and non-smokers, and 3) determine the effect of a 4-week
      treatment with an ICS on albuterol responsiveness of Qaw and the echocardiographic
      parameters. With this protocol the Investigators will test the hypotheses that a) there is a
      correlation between airway and pulmonary vascular endothelial function within the current
      smoker and non-smoker groups, and b) ICS treatment improves airway and pulmonary vascular
      endothelial function in the current smoker group.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      With this protocol the Investigators will test the hypotheses that a) there is a correlation
      between airway and pulmonary vascular endothelial function within the current smoker and
      non-smoker groups, and b) ICS treatment improves airway and pulmonary vascular endothelial
      function in the current smoker group.

      Fifteen healthy current smokers with a &gt;10 pack-year history of smoking and 15 healthy
      never-smokers will be enrolled. Males and females between 25 and 75 years of age will be
      recruited There will be 1-4 visits to the laboratory (one for non-smokers, 4 for smokers).
      All subjects will have the first visit. Current smokers will have 3 additional visits.
      Current smokers will be asked not to smoke before coming to the laboratory on the 3 study
      days. All subjects will be instructed to abstain from ingesting alcoholic beverages, coffee
      or caffeinated drinks for at least 12 hours the night before each study day. The subjects
      will also be instructed not to use PDE5 inhibitors for 24 hours before coming to the
      laboratory. On each study day, the protocol will start at the same time (in the morning).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2013</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">June 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Airway Blood Flow</measure>
    <time_frame>before and 15 minutes after albuterol inhalation</time_frame>
    <description>compare inhaled albuterol-induced changes in airway blood flow (ΔQaw) in healthy current smokers and lifetime non-smokers as an index of endothelial function in the airway circulation and to compare the results between smokers and non-smokers</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Echocardiogram</measure>
    <time_frame>MPAP before and 15 minutes after albuterol inhalation in smokers vs non-smokers</time_frame>
    <description>to compare inhaled albuterol-induced changes in echocardiogram measuring mean pulmonary artery pressure (MPAP)in healthy current smokers and lifetime non-smokers as an index of endothelial function in the pulmonary circulation and to compare the results between smokers and non-smokers</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">31</enrollment>
  <condition>Smoking</condition>
  <arm_group>
    <arm_group_label>smokers</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>participants with smoking history ( &gt; 10 pack/year) will be enrolled and perform airway blood flow and echocardiogram before and 15 minutes after albuterol inhalation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>non-smokers</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>healthy life-time non smokers will be enrolled and perform airway blood flow and echocardiogram before and 15 minutes after albuterol inhalation</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>echocardiogram plus albuterol</intervention_name>
    <description>participants will performed echocardiogram before and 15 minutes after inhaled albuterol</description>
    <arm_group_label>smokers</arm_group_label>
    <arm_group_label>non-smokers</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>airway blood flow plus albuterol</intervention_name>
    <description>participants will performed echocardiogram before and 15 minutes after inhaled albuterol</description>
    <arm_group_label>smokers</arm_group_label>
    <arm_group_label>non-smokers</arm_group_label>
    <other_name>Qaw</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fluticasone propionate</intervention_name>
    <description>participant will be received a 4-week course of inhaled fluticasone (220 μg fluticasone twice a day administered as a MDI using a spacer)</description>
    <arm_group_label>smokers</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>participant will be received a 4-week course of identically appearing placebo (2 puffs twice a day via spacer).</description>
    <arm_group_label>smokers</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Fifteen healthy current smokers with a &gt;10 pack-year history of smoking and 15 healthy
             never-smokers will be enrolled. Males and females between 25 and 75 years of age will
             be recruited.

        Exclusion Criteria:

          -  Women of childbearing potential who do not use accepted birth control measures;
             pregnant and breast feeding women

          -  Cardiovascular disease and/or use of cardiovascular medications

          -  Subjects with known beta-adrenergic agonist intolerance

          -  A physician diagnosis of chronic airway disease (asthma, COPD, bronchiectasis, cystic
             fibrosis)

          -  Acute respiratory infection within four weeks prior to the study

          -  Use of any airway medication

          -  Abnormal pulmonary function
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Adam Wanner, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Miami</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Miami School of Medicine</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 25, 2014</study_first_submitted>
  <study_first_submitted_qc>May 16, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 19, 2014</study_first_posted>
  <results_first_submitted>July 7, 2016</results_first_submitted>
  <results_first_submitted_qc>October 25, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">December 16, 2016</results_first_posted>
  <last_update_submitted>October 25, 2016</last_update_submitted>
  <last_update_submitted_qc>October 25, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 16, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Miami</investigator_affiliation>
    <investigator_full_name>Adam Wanner</investigator_full_name>
    <investigator_title>Research Professor</investigator_title>
  </responsible_party>
  <keyword>smokers</keyword>
  <keyword>airway blood flow</keyword>
  <keyword>fluticasone</keyword>
  <keyword>echocardiogram</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fluticasone</mesh_term>
    <mesh_term>Albuterol</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Smokers</title>
          <description>participants will performed airway blood flow and echocardiogram before and 15 minutes after inhalation of albuterol.
echocardiogram: participants will performed echocardiogram before and 15 minutes after inhaled albuterol
airway blood flow: participants will performed echocardiogram before and 15 minutes after inhaled albuterol</description>
        </group>
        <group group_id="P2">
          <title>Non-smokers</title>
          <description>participants will performed airway blood flow and echocardiogram before and 15 minutes after inhalation of albuterol
echocardiogram: participants will performed echocardiogram before and 15 minutes after inhaled albuterol
airway blood flow: participants will performed echocardiogram before and 15 minutes after inhaled albuterol</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="16"/>
                <participants group_id="P2" count="15"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
                <participants group_id="P2" count="15"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Smokers</title>
          <description>echocardiogram: participants will performed echocardiogram before and 15 minutes after inhaled albuterol
airway blood flow: participants will performed echocardiogram before and 15 minutes after inhaled albuterol</description>
        </group>
        <group group_id="B2">
          <title>Non-smokers</title>
          <description>echocardiogram: participants will performed echocardiogram before and 15 minutes after inhaled albuterol
airway blood flow: participants will performed echocardiogram before and 15 minutes after inhaled albuterol</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="16"/>
            <count group_id="B2" value="15"/>
            <count group_id="B3" value="31"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="31"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="47.6" spread="2.0"/>
                    <measurement group_id="B2" value="44.7" spread="2.0"/>
                    <measurement group_id="B3" value="46.2" spread="2.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="19"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Airway Blood Flow</title>
        <description>compare inhaled albuterol-induced changes in airway blood flow (ΔQaw) in healthy current smokers and lifetime non-smokers as an index of endothelial function in the airway circulation and to compare the results between smokers and non-smokers</description>
        <time_frame>before and 15 minutes after albuterol inhalation</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Smokers</title>
            <description>participants will performed airway blood flow and echocardiogram before and 15 minutes after inhalation of albuterol.
echocardiogram: participants will performed echocardiogram before and 15 minutes after inhaled albuterol
airway blood flow: participants will performed echocardiogram before and 15 minutes after inhaled albuterol</description>
          </group>
          <group group_id="O2">
            <title>Non-smokers</title>
            <description>participants will performed airway blood flow and echocardiogram before and 15 minutes after inhalation of albuterol
echocardiogram: participants will performed echocardiogram before and 15 minutes after inhaled albuterol
airway blood flow: participants will performed echocardiogram before and 15 minutes after inhaled albuterol</description>
          </group>
        </group_list>
        <measure>
          <title>Airway Blood Flow</title>
          <description>compare inhaled albuterol-induced changes in airway blood flow (ΔQaw) in healthy current smokers and lifetime non-smokers as an index of endothelial function in the airway circulation and to compare the results between smokers and non-smokers</description>
          <units>ΔQaw (ul/min/ml)</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.13" spread="2.52"/>
                    <measurement group_id="O2" value="13.05" spread="1.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Echocardiogram</title>
        <description>to compare inhaled albuterol-induced changes in echocardiogram measuring mean pulmonary artery pressure (MPAP)in healthy current smokers and lifetime non-smokers as an index of endothelial function in the pulmonary circulation and to compare the results between smokers and non-smokers</description>
        <time_frame>MPAP before and 15 minutes after albuterol inhalation in smokers vs non-smokers</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Smokers</title>
            <description>participants will performed airway blood flow and echocardiogram before and 15 minutes after inhalation of albuterol.
echocardiogram: participants will performed echocardiogram before and 15 minutes after inhaled albuterol
airway blood flow: participants will performed echocardiogram before and 15 minutes after inhaled albuterol</description>
          </group>
          <group group_id="O2">
            <title>Non-smokers</title>
            <description>participants will performed airway blood flow and echocardiogram before and 15 minutes after inhalation of albuterol
echocardiogram: participants will performed echocardiogram before and 15 minutes after inhaled albuterol
airway blood flow: participants will performed echocardiogram before and 15 minutes after inhaled albuterol</description>
          </group>
        </group_list>
        <measure>
          <title>Echocardiogram</title>
          <description>to compare inhaled albuterol-induced changes in echocardiogram measuring mean pulmonary artery pressure (MPAP)in healthy current smokers and lifetime non-smokers as an index of endothelial function in the pulmonary circulation and to compare the results between smokers and non-smokers</description>
          <units>ΔMPAP (mmHg)</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-7.70" spread="1.37"/>
                    <measurement group_id="O2" value="-9.04" spread="0.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>2 years and 10 month</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Smokers</title>
          <description>No AE or SAE had occurred</description>
        </group>
        <group group_id="E2">
          <title>Non-smokers</title>
          <description>No AE or SAE had occurred</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr Adam Wanner Professor of Medicine Division of Pulmonary and Critical Care Medicine</name_or_title>
      <organization>University of Miami</organization>
      <phone>(305) 243-3045</phone>
      <email>awanner@med.miami.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

